Fiche centre
Xuanwu Hospital, Capital Medical University
Beijing — China
Essais liés8clinical trials
VilleBeijinglocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07835152
Essais cliniques associés
8| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Transcranial Temporal Interference Stimulation (tTIs) | Accident vasculaire cérébral | Non applicable | NCT07896629 | TIMES — Temporal Interference Stimulation for Upper-Limb Motor Recovery in Early Subacute Stroke | NOT_YET_RECRUITING |
| BR005-036C | Migraine | Phase 3 | NCT07835152 | Long-term Safety of BR005-036C Tablets in the Acute Treatment of Migraine in Adults | NOT_YET_RECRUITING |
| Trontinemab | Alzheimer | Phase 3 | NCT07717411 | PrevenTRON — A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease | RECRUITING |
| BR005-036C | Migraine | Phase 2/3 | NCT07792681 | Efficacy and Safety of BR005-036C Tablets for the Acute Treatment of Migraine in Adults | RECRUITING |
| TIE — Temporal Interference for Drug Resistant Epilepsy | Épilepsie | Non applicable | NCT06708143 | TIE — Temporal Interference for Drug Resistant Epilepsy | RECRUITING |
| Prasinezumab | Parkinson | Phase 3 | NCT07174310 | PARAISO — A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease | RECRUITING |
| TJ0113 200mg | Parkinson | Phase 3 | NCT07741045 | Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients With Early-Onset Parkinson's Disease | NOT_YET_RECRUITING |
| doublepres — The Diagnosis and Treatment of Resistant Hypertension, the Prevalence and the Prognosis | Hypertension | À vérifier | NCT01703780 | doublepres — The Diagnosis and Treatment of Resistant Hypertension, the Prevalence and the Prognosis | UNKNOWN |